Edited by Maureen McKelvey, Professor, School of Business, Economics and Law, University of Gothenburg, Annika Rickne, Professor, Royal Institute of Technology and Jens Laage-Hellman, Associate Professor, Department of Technology Management and Economics, Chalmers University of Technology, Sweden

• Contents: Preface Part I: Introduction 1. Introduction Jens Laage-Hellman, Maureen McKelvey and Annika Rickne2. Conceptualizing and Measuring Modern Biotechnology Johan Brink, Maureen McKelvey and Keith SmithPart II: Setting the Scene 3. Stylized Facts about Innovation Processes in Modern Biotechnology Maureen McKelvey, Annika Rickne and Jens Laage-Hellman4. The Post-Genome Era: Rupture in the Organization of the Life Science Industry? Michel Quéré5. An Overview of Biotechnology Innovation in Europe: Firms, Demand, Government Policy and Research Jacqueline SenkerPart III: Challenging the Existing 6. Risk Management and the Commercialization of Human Genetic Testing in the UK Michael M. Hopkins and Paul Nightingale7. Network and Technology Systems in Science-driven Fields: The Case of European Food Biotechnology Finn Valentin and Rasmus Lund Jensen8. Future Imperfect: The Response of the Insurance Industry to the Emergence of Predictive Genetic Testing Stefano Brusoni, Rachel Cutts and Aldo Geuna9. Emergent Bioinformatics and Newly Distributed Innovation Processes Andrew McMeekin, Mark Harvey and Sally GeePart IV: Forming the New 10. The Dynamics of Regional Specialization in Modern Biotechnology: Comparing Two Regions in Sweden and Two Regions in Australia, 1977–2001 Johan Brink, Linus Dahlander and Maureen McKelvey11. On the Spatial Dimension of Firm Formation Annika Rickne12. Examining the Marketplace for Ideas: How Local are Europe’s Biotechnology Clusters? Steven Casper and Fiona Murray13. Creation and Growth of High-Tech SMEs: The Role of the Local Environment Corinne Autant-Bernard, Vincent Mangematin and Nadine MassardPart V: Conclusions 14. Reflections and Ways Forward Hannah Kettler, Maureen McKelvey and Luigi OrsenigoIndex

'All would agree that with more than 3,000 new firms formed in Europe, Japan and the United States focused on biotechnology, and with elegant strides forward in our understanding of genetics, the genome, proteomics and other related fields, a true intellectual, social and industrial revolution is in the making. Maureen McKelvey et al provide fascinating data on firm formation, case studies of emerging business models and cross-regional and national comparisons. The work is a useful beginning in our understanding of an emerging phenomenon.'